Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients.

Publication | Closed Access

DOI

Citations

References

1996

Year

P Colonna, B Desablens, J L Harousseau, J Brière, M Boasson, A. Lemevel, Philippe Casassus, P. Y. Le Prise, François Guilhot, C Ghandour,

Journal of Clinical Oncology

Abstract

References